Structure Therapeutics
Didi H. has a diverse work experience in the field of scientific research and structural biology. They started their career as a Demonstrator at The University of Edinburgh in January 2017 and worked until September 2019. From May 2017 to October 2020, they worked as a Novo Nordisk Postdoc Research Fellow at the SGC - University of Oxford. They then joined Confo Therapeutics in November 2020 as a Scientist in Structural Biology and worked until December 2021. In February 2022, they joined Basecamp Bio as a Principal Scientist and worked until December 2022. Currently, Didi H. is working as a Principal Scientist at Structure Therapeutics since January 2023.
Didi H. completed a Bachelor's Degree in Biosciences at Anhui Agricultural University from 2006 to 2010. Following this, they pursued a Master of Science (MS) in Microbiology from Shandong University from 2010 to 2013. Didi H. furthered their education by obtaining a Doctor of Philosophy (Ph.D.) in Structural and Molecular Biology from The University of Edinburgh, completing their degree from 2013 to 2017.
This person is not in any offices
Structure Therapeutics
Structure Therapeutics creates life-changing medicines for patients using advanced computational and structure-based technology. Our platform combines the latest advancements in computational chemistry, visualization of molecular interactions, and data integration to design orally available, superior medicines that overcome current limitations inbiologic and peptide drugs. We are advancing our clinical-stage pipeline of differentiated, efficacious and safe treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic and pulmonary conditions. At Structure, our team’s deep experience with complex biological targets and mechanisms, structure-based drug design, and global drug discovery and development enables our bold vision: to design and develop world-class medicines with tremendous patient impact and broad commercial opportunity.